Teladoc Health, Inc. (FRA:4LL)
Germany · Delayed Price · Currency is EUR 4.587
-0.113 (-2.40%)
At close: Jan 30, 2026
Teladoc Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -223.59 | -1,001 | -220.37 | -13,660 | -428.79 | -485.14 |
Depreciation & Amortization | 204.88 | 249.81 | 265.76 | 221.69 | 219.62 | 70.59 |
Other Amortization | 164 | 133.04 | 82.96 | 46.1 | - | 7.5 |
Asset Writedown & Restructuring Costs | 71.76 | 790 | - | 13,403 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | -5.9 | - |
Stock-Based Compensation | 91.98 | 145.95 | 201.55 | 217.85 | 302.59 | 475.53 |
Provision & Write-off of Bad Debts | 1.12 | 3.8 | 4.69 | 2.82 | 10.6 | 5.28 |
Other Operating Activities | -25.35 | 8.65 | 3.79 | 5.95 | 139.86 | -36.79 |
Change in Accounts Receivable | 3.61 | -0.38 | -10.25 | -49.06 | -11.17 | -21.09 |
Change in Inventory | -2.46 | -9.75 | 24.1 | 14.8 | -19.49 | -24.73 |
Change in Accounts Payable | 11.74 | -10.37 | -4.18 | 1.88 | 1.19 | -88 |
Change in Unearned Revenue | -17.57 | -18.25 | -4.9 | 15.24 | 20.55 | 17.75 |
Change in Other Net Operating Assets | 12.39 | 2.42 | 6.89 | -31.25 | -35.06 | 25.58 |
Operating Cash Flow | 292.52 | 293.68 | 350.02 | 189.29 | 193.99 | -53.51 |
Operating Cash Flow Growth | -13.42% | -16.10% | 84.91% | -2.42% | - | - |
Capital Expenditures | -12.41 | -10.79 | -11.46 | -16.48 | -8.53 | -4.02 |
Cash Acquisitions | -81.9 | - | - | - | -78.66 | -567.43 |
Sale (Purchase) of Intangibles | -139.94 | -113.26 | -144.88 | -156.28 | -55.4 | -22.02 |
Investment in Securities | -27.14 | - | - | 2.51 | 60.9 | 2.5 |
Other Investing Activities | 0.06 | - | 0 | 2.51 | 8.72 | - |
Investing Cash Flow | -261.33 | -124.05 | -156.35 | -167.74 | -72.98 | -590.98 |
Long-Term Debt Issued | - | - | - | - | - | 1,098 |
Long-Term Debt Repaid | - | - | - | - | - | -246.79 |
Net Debt Issued (Repaid) | -550.63 | - | - | - | - | 850.87 |
Issuance of Common Stock | 3.86 | 8.31 | 11.13 | 12.39 | 42.59 | 59.04 |
Repurchase of Common Stock | - | - | - | - | - | -26.7 |
Other Financing Activities | -3.93 | -0 | -0.28 | -5.89 | -1.64 | -24.07 |
Financing Cash Flow | -550.7 | 8.31 | 10.85 | 6.5 | 40.95 | 859.14 |
Foreign Exchange Rate Adjustments | 1.89 | -3.29 | 0.97 | -3.34 | -1.8 | 4.32 |
Net Cash Flow | -517.62 | 174.65 | 205.49 | 24.7 | 160.16 | 218.97 |
Free Cash Flow | 280.11 | 282.89 | 338.56 | 172.81 | 185.46 | -57.54 |
Free Cash Flow Growth | -15.58% | -16.44% | 95.91% | -6.82% | - | - |
Free Cash Flow Margin | 11.08% | 11.01% | 13.01% | 7.18% | 9.12% | -5.26% |
Free Cash Flow Per Share | 1.60 | 1.66 | 2.06 | 1.07 | 1.18 | -0.64 |
Cash Interest Paid | 17.32 | 17.32 | 17.42 | 17.36 | 18.84 | 14.89 |
Cash Income Tax Paid | 7.48 | 8.95 | 7.24 | 2.51 | 3.97 | 1.32 |
Levered Free Cash Flow | 206.56 | 229.78 | 303.95 | 176.62 | 241.62 | 206.75 |
Unlevered Free Cash Flow | 220.07 | 244.65 | 317.88 | 190.34 | 292.34 | 244.22 |
Change in Working Capital | 7.72 | -36.32 | 11.64 | -48.39 | -43.99 | -90.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.